Mountain Crest Acquisition Corp. V

The momentum for this stock is not very good. Mountain Crest Acquisition Corp. V is not very popular among insiders. Tradey thinks it is not wise to invest in Mountain Crest Acquisition Corp. V.
Log in to see more information.

News

CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed
CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed

Globe Newswire NEW YORK, USA and SEOUL, Korea, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company ( Mountain Crest V...\n more…

CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V
CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V

Globe Newswire NEW YORK, USA and SEOUL, Korea, May 02, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation ( Mountain Crest V ), that is a Nasdaq-listed (Nasdaq: MCAG) special...\n more…

AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer
AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer

Globe Newswire SINGAPORE and BETHESDA, Md., May 30, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (AUM), a global clinical-stage biotechnology company focused on discovering and developing precision oncology therapeutics, announced today that the first patient has been dosed in its Phase 2 clinical trial ...\n more…

AUM Biosciences to Participate in Inaugural EF Hutton Global Conference
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference

Globe Newswire SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (AUM), a global clinical-stage biotechnology company focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance, ...\n more…